91.91
Ani Pharmaceuticals Inc 주식(ANIP)의 최신 뉴스
MACD Signals Flash Warning for ANI Pharmaceuticals Inc. StockMarket Performance Recap & Fast Entry High Yield Tips - newsyoung.net
Ani Pharmaceuticals stock hits 52-week high at 90.43 USD By Investing.com - Investing.com Nigeria
Ani Pharmaceuticals Executives Sell Shares Amid Market Volatility - AInvest
ANI Pharmaceuticals' Insider Sales: Strategic Liquidity or a Warning Signal for Shareholders? - AInvest
Insider Selling at ANI Pharmaceuticals: A Cautionary Signal Amidst Strong Earnings and Analyst Optimism? - AInvest
Shanmugam Muthusamy of Ani Pharmaceuticals sells $8.8m in stock - Investing.com
Ani Pharmaceuticals Insider Sold Shares Worth $801,450, According to a Recent SEC Filing - MarketScreener
Shanmugam Muthusamy of Ani Pharmaceuticals sells $8.8m in stock By Investing.com - Investing.com UK
Ani Pharmaceuticals stock hits 52-week high at 90.43 USD - Investing.com India
Momentum Screeners Rank ANI Pharmaceuticals Inc. in Top 5 Today2025 Institutional Moves & Real-Time Volume Analysis Alerts - classian.co.kr
Will ANI Pharmaceuticals Inc. Hold Gains Into CloseMarket Weekly Review & Consistent Income Trade Ideas - newsimpact.co.kr
ANI gets FDA approval for generic Motegrity - MSN
ANI Pharmaceuticals, Berkshire Hathaway, Chevron - TradingView
Using R and stats models for ANI Pharmaceuticals Inc. forecastingStop Loss & Weekly Top Gainers Trade List - Newser
Advanced analytics toolkit walkthrough for ANI Pharmaceuticals Inc.Market Performance Recap & Real-Time Sentiment Analysis - Newser
ANI Pharmaceuticals Inc. stock daily chart insights2025 Support & Resistance & Risk Managed Investment Strategies - Newser
Published on: 2025-08-17 01:40:35 - Newser
ANI Pharmaceuticals Inc. stock outlook for YEAR2025 Major Catalysts & AI Powered Buy/Sell Recommendations - Newser
Trend analysis for ANI Pharmaceuticals Inc. this weekWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
This Insider Has Just Sold Shares In ANI Pharmaceuticals - simplywall.st
ANI Pharmaceuticals Inc.’s Price Action Aligns with Quant SignalsConsistent High Return Strategy - beatles.ru
Technical signs of recovery in ANI Pharmaceuticals Inc.July 2025 Short Interest & Breakout Confirmation Trade Signals - Newser
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Rating Upgraded by Wall Street Zen - Defense World
Assessing Insider Selling at ANI Pharmaceuticals: Confidence or Concern? - AInvest
Chart based exit strategy for ANI Pharmaceuticals Inc.July 2025 PostEarnings & AI Based Buy/Sell Signal Reports - Newser
Nikhil Lalwani Sells 56,960 Shares of ANI Pharmaceuticals Inc, Insider Now Owns 411,219 Shares - AInvest
Leerink Partners Maintains Buy Rating on ANI Pharmaceuticals with $100 Price Target - AInvest
ANI Pharmaceuticals Inc. recovery potential after sell offJuly 2025 Setups & Entry and Exit Point Strategies - Newser
ANI Pharmaceuticals' Insider Sale: A Strategic Warning or a Misread Opportunity? - AInvest
The 5 Most Interesting Analyst Questions From ANI Pharmaceuticals’s Q2 Earnings Call - Yahoo Finance
Can ANI Pharmaceuticals Inc. Overcome Bearish SentimentBear Alert & Smart Allocation Stock Reports - sundaytimes.kr
Nikhil Lalwani, president of ANI Pharmaceuticals, sells $4.89m in stock - Investing.com Nigeria
Ani Pharmaceuticals SVP, Gutwerg, sells $508,190 in stock By Investing.com - Investing.com Nigeria
Ani Pharmaceuticals SVP, Gutwerg, sells $508,190 in stock - Investing.com
ANI Pharmaceuticals director Haughey sells $1.66 million in stock - Investing.com
Ani Pharmaceuticals SVP Carey sells $4.3m in shares By Investing.com - Investing.com Australia
Ani Pharmaceuticals’ Cook sells $35k in stock - Investing.com
Ani Pharmaceuticals SVP Carey sells $4.3m in shares - Investing.com India
Rowland, SVP at Ani Pharmaceuticals, sells $426k in stock - Investing.com India
ANI Pharmaceuticals director Haughey sells $1.66 million in stock By Investing.com - Investing.com Canada
Rowland, SVP at Ani Pharmaceuticals, sells $426k in stock By Investing.com - Investing.com Australia
ANI Pharmaceuticals' Insider Sales: Liquidity or Lack of Confidence? - AInvest
Insider Selling at ANI Pharmaceuticals: Liquidity Moves or Lack of Confidence? - AInvest
Council approves plans for pharmaceutical manufacturing facility - veronapress.com
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q2 2025 Earnings Call Transcript - MSN
Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know - Yahoo Finance
Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know | FinancialContent - FinancialContent
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Price Expected to Rise, Truist Financial Analyst Says - Defense World
ANI Pharmaceuticals Inc. Surpasses Analyst Target Price of $83.12 - AInvest
자본화:
|
볼륨(24시간):